Total Payments
$8,781
2023 Payments
$28.81
Companies
42
Transactions
529
Medicare Patients
1,228
Medicare Billing
$66,777
Payment Breakdown by Category
Food & Beverage$8,732 (99.4%)
Education$48.76 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,732 | 524 | 99.4% |
| Education | $48.76 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,411 | 70 | $0 (2022) |
| PFIZER INC. | $857.54 | 51 | $0 (2022) |
| ABBVIE INC. | $788.53 | 41 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $662.21 | 22 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $371.06 | 19 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $370.32 | 24 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $366.36 | 30 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $354.75 | 37 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $350.02 | 22 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $345.28 | 54 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.81 | 1 | Organon LLC ($28.81) |
| 2022 | $253.82 | 10 | AstraZeneca Pharmaceuticals LP ($89.81) |
| 2021 | $1,879 | 98 | AbbVie Inc. ($600.92) |
| 2020 | $1,479 | 110 | Kowa Pharmaceuticals America, Inc. ($234.18) |
| 2019 | $1,424 | 106 | Amgen Inc. ($320.38) |
| 2018 | $2,460 | 114 | Amgen Inc. ($437.41) |
| 2017 | $1,256 | 90 | Novartis Pharmaceuticals Corporation ($164.50) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: ETONOGESTREL | ||||||
| 05/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: VACCINES | ||||||
| 03/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: PRIMARY CARE | ||||||
| 02/17/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: Cardiovascular | ||||||
| 02/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Bone Health | ||||||
| 01/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/06/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $89.81 | General |
| 01/03/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/24/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PRIMARY CARE | ||||||
| 12/14/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.51 | General |
| 12/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: DIABETES | ||||||
| 12/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 12/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: DIABETES | ||||||
| 11/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: DIABETES | ||||||
| 11/10/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 159 | 187 | $32,583 | $7,736 |
| 2022 | 6 | 181 | 221 | $18,038 | $6,006 |
| 2021 | 12 | 737 | 1,158 | $82,236 | $45,364 |
| 2020 | 6 | 151 | 188 | $21,488 | $7,670 |
Total Patients
1,228
Total Services
1,754
Medicare Billing
$66,777
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 50 | $20,650 | $3,761 | 18.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $9,262 | $2,825 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 31 | 39 | $327.00 | $298.48 | 91.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 16 | 18 | $648.00 | $236.16 | 36.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 18 | $522.00 | $186.30 | 35.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 11 | 11 | $495.00 | $181.06 | 36.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 14 | $364.00 | $133.28 | 36.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 14 | 15 | $315.00 | $114.15 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 75 | $11,486 | $3,053 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 34 | $3,570 | $1,750 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 36 | 39 | $1,481 | $411.00 | 27.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 29 | 30 | $732.00 | $401.43 | 54.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 30 | $556.00 | $290.92 | 52.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 12 | 13 | $213.00 | $100.53 | 47.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 326 | $47,738 | $26,637 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 115 | $11,893 | $7,019 | 59.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $3,956 | $2,914 | 73.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 32 | 33 | $2,260 | $2,127 | 94.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 97 | 149 | $3,576 | $1,995 | 55.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 111 | 173 | $6,747 | $1,827 | 27.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 87 | 129 | $2,322 | $1,253 | 53.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 30 | 31 | $930.00 | $531.68 | 57.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 57 | 60 | $918.00 | $466.20 | 50.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 47 | 55 | $550.00 | $342.65 | 62.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 45 | 52 | $1,094 | $156.00 | 14.3% |
About Dr. Dennis Morrisroe, M.D
Dr. Dennis Morrisroe, M.D is a Family Medicine healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659553741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dennis Morrisroe, M.D has received a total of $8,781 in payments from pharmaceutical and medical device companies, with $28.81 received in 2023. These payments were reported across 529 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,732).
As a Medicare-enrolled provider, Morrisroe has provided services to 1,228 Medicare beneficiaries, totaling 1,754 services with total Medicare billing of $66,777. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Vancouver, WA
- Active Since 11/29/2007
- Last Updated 03/29/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659553741
Products in Payments
- Aimovig (Biological) $586.05
- VRAYLAR (Drug) $378.39
- ENTRESTO (Drug) $370.32
- CHANTIX (Drug) $361.82
- Livalo (Drug) $345.28
- EVENITY (Biological) $339.60
- UBRELVY (Drug) $327.53
- FARXIGA (Drug) $300.13
- Prolia (Biological) $286.16
- ELIQUIS (Drug) $264.48
- TOUJEO (Drug) $263.87
- XARELTO (Drug) $217.52
- JANUVIA (Drug) $197.17
- MYDAYIS (Drug) $195.96
- Vascepa (Drug) $181.13
- Ozempic (Drug) $167.67
- MYRBETRIQ (Drug) $154.27
- JARDIANCE (Drug) $150.44
- INTRAROSA (Drug) $142.30
- TRADJENTA (Drug) $137.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vancouver
Antonio Carrasco, Md, Phd, MD, PHD
Family Medicine — Payments: $122,260
Family Medicine $122,260
Mrs. Susan Hughes, Md, MD
Family Medicine — Payments: $39,359
Family Medicine $39,359
Rick Jackson, M.d, M.D
Family Medicine — Payments: $28,554
Family Medicine $28,554
Dr. Donald Benz, Md, MD
Family Medicine — Payments: $21,156
Family Medicine $21,156
Dr. Bernard Stupski, D.o, D.O
Family Medicine — Payments: $19,021
Family Medicine $19,021
Christopher Vantilburg, Md, MD
Family Medicine — Payments: $8,963
Family Medicine $8,963